Cargando…

COVID-19 Omicron variant-induced laryngitis

OBJECTIVES: The COVID-19 omicron variant has a low affinity for the lower respiratory tract. However, upper respiratory tract symptoms, such as nasal discharge and sore throat, characterize the infection with this variant. Therefore, in laryngeal stenosis, disease severity assessment through blood o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Yurika, Hirabayashi, Eiko, Yano, Mai, Fujitani, Satoru, Shioiri, Sadaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395289/
https://www.ncbi.nlm.nih.gov/pubmed/36114072
http://dx.doi.org/10.1016/j.anl.2022.08.007
_version_ 1784771657966026752
author Kimura, Yurika
Hirabayashi, Eiko
Yano, Mai
Fujitani, Satoru
Shioiri, Sadaaki
author_facet Kimura, Yurika
Hirabayashi, Eiko
Yano, Mai
Fujitani, Satoru
Shioiri, Sadaaki
author_sort Kimura, Yurika
collection PubMed
description OBJECTIVES: The COVID-19 omicron variant has a low affinity for the lower respiratory tract. However, upper respiratory tract symptoms, such as nasal discharge and sore throat, characterize the infection with this variant. Therefore, in laryngeal stenosis, disease severity assessment through blood oxygen saturation has not been useful. METHODS: We report the case of “omicron laryngitis” in a 59-year-old male who visited the ear, nose, and throat (ENT) clinic with complaints of a sore throat and difficulty in swallowing saliva that persisted for a day. RESULTS: Laryngoscopy revealed severe swelling of the transglottic region and exudates on the larynx. He was then diagnosed with COVID-19 and subjected to emergency tracheostomy for airway management. Until the emergence of the omicron variant, COVID-19 showed mainly lower airway and mild upper airway inflammatory features. However, upper airway stenosis should be suspected in cases presenting with “muffled speech,” “dysphagia,” “severe pain on swallowing,” and “inspiratory dyspnea or stridor.” CONCLUSION: Therefore, laryngeal and pharyngeal evaluation using a flexible laryngoscope under appropriate infection control measures is necessary, considering the possibility of progression to fatal laryngeal stenosis, as noted in this case.
format Online
Article
Text
id pubmed-9395289
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-93952892022-08-23 COVID-19 Omicron variant-induced laryngitis Kimura, Yurika Hirabayashi, Eiko Yano, Mai Fujitani, Satoru Shioiri, Sadaaki Auris Nasus Larynx Article OBJECTIVES: The COVID-19 omicron variant has a low affinity for the lower respiratory tract. However, upper respiratory tract symptoms, such as nasal discharge and sore throat, characterize the infection with this variant. Therefore, in laryngeal stenosis, disease severity assessment through blood oxygen saturation has not been useful. METHODS: We report the case of “omicron laryngitis” in a 59-year-old male who visited the ear, nose, and throat (ENT) clinic with complaints of a sore throat and difficulty in swallowing saliva that persisted for a day. RESULTS: Laryngoscopy revealed severe swelling of the transglottic region and exudates on the larynx. He was then diagnosed with COVID-19 and subjected to emergency tracheostomy for airway management. Until the emergence of the omicron variant, COVID-19 showed mainly lower airway and mild upper airway inflammatory features. However, upper airway stenosis should be suspected in cases presenting with “muffled speech,” “dysphagia,” “severe pain on swallowing,” and “inspiratory dyspnea or stridor.” CONCLUSION: Therefore, laryngeal and pharyngeal evaluation using a flexible laryngoscope under appropriate infection control measures is necessary, considering the possibility of progression to fatal laryngeal stenosis, as noted in this case. Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. 2023-08 2022-08-23 /pmc/articles/PMC9395289/ /pubmed/36114072 http://dx.doi.org/10.1016/j.anl.2022.08.007 Text en © 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kimura, Yurika
Hirabayashi, Eiko
Yano, Mai
Fujitani, Satoru
Shioiri, Sadaaki
COVID-19 Omicron variant-induced laryngitis
title COVID-19 Omicron variant-induced laryngitis
title_full COVID-19 Omicron variant-induced laryngitis
title_fullStr COVID-19 Omicron variant-induced laryngitis
title_full_unstemmed COVID-19 Omicron variant-induced laryngitis
title_short COVID-19 Omicron variant-induced laryngitis
title_sort covid-19 omicron variant-induced laryngitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395289/
https://www.ncbi.nlm.nih.gov/pubmed/36114072
http://dx.doi.org/10.1016/j.anl.2022.08.007
work_keys_str_mv AT kimurayurika covid19omicronvariantinducedlaryngitis
AT hirabayashieiko covid19omicronvariantinducedlaryngitis
AT yanomai covid19omicronvariantinducedlaryngitis
AT fujitanisatoru covid19omicronvariantinducedlaryngitis
AT shioirisadaaki covid19omicronvariantinducedlaryngitis